Analysis of pharmacogenomic studies requires different skills and approaches from the statistical methods normally used in clinical studies. However it is critical that the genomic methods are embedded in the more conventional analytical methods used in studies, as the clinical parameters measured during the study form a central part of the pharmacogenomic analysis.

With its experience in the area and access to leading edge analytical methodologies, PGXIS will ensure that the right genetics statistics expertise is integrated into the analysis of the study data.